XML 48 R35.htm IDEA: XBRL DOCUMENT
v3.23.2

Earnings Per Share (Tables) | 12 Months Ended
--- | ---
Jul. 01, 2023
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share | The following table sets forth the computation of basic and diluted net income per share (in millions, except per share data):
| Years Ended
| July 1, 2023 |  | July 2, 2022 |  | July 3, 2021
Numerator: |  |  |  |  |
Net income | $ | 25.5 |  |  | $ | 15.5 |  |  | $ | 67.5 |
Denominator: |  |  |  |  |
Weighted-average shares outstanding: |  |  |  |  |
Basic | 224.6 |  |  | 230.9 |  |  | 228.7 |
Shares issuable assuming conversion of convertible notes(1) | 0.3 |  |  | 4.8 |  |  | 5.0 |
Effect of dilutive securities from stock-based compensation plans | 1.7 |  |  | 2.5 |  |  | 2.6 |
Diluted | 226.6 |  |  | 238.2 |  |  | 236.3 |
Net income per share: |  |  |  |  |
Basic | $ | 0.11 |  |  | $ | 0.07 |  |  | $ | 0.30 |
Diluted | $ | 0.11 |  |  | $ | 0.07 |  |  | $ | 0.29 |
(1) Represents the dilutive impact for the Company's 1.75% Senior Convertible Notes due 2023 (2023 Notes), the 1.00% Senior Convertible Notes due 2024 (2024 Notes) and the 1.625% Senior Convertible Notes due 2026 (2026 Notes). The par amount of the Company’s convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and the “in-the money” conversion benefit feature above the conversion price is payable in cash, shares of the Company’s common stock or a combination of both, at the Company’s election. Refer to “Note 11. Debt” for more information.
Schedule of Antidilutive Securities | The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income per share because their effect would have been anti-dilutive (in millions):
| Years Ended
| July 1, 2023 |  | July 2, 2022 |  | July 3, 2021
Full Value Awards(1) | 3.7 |  |  | 0.6 |  |  | 0.4 |
(1) See Note 16. Stock-Based Compensation for definition of Full Value Awards.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration